Company profile

imuveo

imuveo | Seeing and treating cancer through CD2 targeted and precise radiopharmaceuticals

Industry
Biotechnology Research
Employees
6
Headquarters
München, Bayern
LinkedIn followers
1,476
Office locations
1

imuveo company summary

imuveo is a company in the Biotechnology Research industry, headquartered in München, Bayern. On LinkedIn the company has around 6 employees and 1,476 followers.

What technology does imuveo use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About imuveo

At imuveo, we are advancing precision radiopharmaceutical science to transform cancer care. We develop CD2 targeted radiopharma across two complementary programmes: • Therapy monitoring Our CD2 targeted imaging agents provide clinicians with actionable, immune-centric insights into how patients are responding to immunotherapy. By making T cell dynamics visible in real time, we help improve treatment decisions and individualize care. • Theranostic We are building CD2 targeted theranostic radioligand therapies designed to precisely deliver therapeutic radiation to T cell driven malignancies. This approach harnesses the specificity of CD2 targeting to maximize anti-tumor effects while limiting off-target toxicity. imuveo has advanced lead tracers into the clinic, generating first human data that demonstrate safety, target engagement, and potential for impact in oncology. Our radiopharmaceutical platform is positioned to support both better therapy decision making and next-generation targeted therapy options across immuno-oncology.

Where is imuveo located?

imuveo lists 1 location.

München, Bayern, DEHQ

Compare companies similar to imuveo

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
imuveo
imuveo.de
Biotechnology Research6-München, Bayern
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about imuveo

What does imuveo do?

At imuveo, we are advancing precision radiopharmaceutical science to transform cancer care. We develop CD2 targeted radiopharma across two complementary programmes: • Therapy monitoring Our CD2 targeted imaging agents provide clinicians with actionable, immune-centric insights into how patients are responding to immunotherapy. By making T cell dynamics visible in real time, we help improve treatment decisions and individualize care. • Theranostic We are building CD2 targeted theranostic radioligand therapies designed to precisely deliver therapeutic radiation to T cell driven malignancies. This approach harnesses the specificity of CD2 targeting to maximize anti-tumor effects while limiting off-target toxicity. imuveo has advanced lead tracers into the clinic, generating first human data that demonstrate safety, target engagement, and potential for impact in oncology. Our radiopharmaceutical platform is positioned to support both better therapy decision making and next-generation targeted therapy options across immuno-oncology.

How many employees does imuveo have?

imuveo has around 6 employees on LinkedIn.

Where is imuveo headquartered?

imuveo is headquartered in München, Bayern.

Build a lead list from companies like imuveo

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.